Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Cardiology

Journal Scan / Research · November 25, 2024

Relative Benefit of Dual vs Single Antiplatelet Therapy Among Patients With Atrial Fibrillation on Oral Anticoagulation According to Time After ACS and PCI

Circulation: Cardiovascular Interventions

 

Additional Info

Disclosure statements are available on the authors' profiles:

Circulation: Cardiovascular Interventions
Relative Benefit of Dual Versus Single Antiplatelet Therapy Among Patients With Atrial Fibrillation on Oral Anticoagulation According to Time After ACS and PCI: Insights From the AUGUSTUS Trial
Circ Cardiovasc Interv 2024 Nov 06;[EPub Ahead of Print], AC Fanaroff, DM Wojdyla, CB Granger, SG Goodman, RS Aronson, S Windecker, R Mehran, JH Alexander, RD Lopes

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading